Effect of repeated capsaicin ingestion on intestinal chemosensation and mechanosensation

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 4, 2006, Pages 679-686

  Hammer, J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; PLACEBO;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BALLOON; BURNING SENSATION; CALCULATION; CLINICAL TRIAL; COLIC; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; JEJUNUM; MALE; NAUSEA; NOCICEPTION; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSATION;

ADMINISTRATION, ORAL; ADULT; BALLOON OCCLUSION; CAPSAICIN; CAPSULES; DYSPEPSIA; FEMALE; HUMANS; MALE; NOCICEPTORS; PRESSURE; SENSORY THRESHOLDS; TRPV CATION CHANNELS;

EID: 33746455735     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03022.x     Document Type: Article

References (46)

1. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991; 43: 143-201.
2. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159-211.
3. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-24.
4. Szallasi A, Di Marzo V. New perspectives on enigmatic vanilloid receptors. Trends Neurosci 2000; 23: 491-7.
5. Tominaga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998; 21: 531-43.
6. Trevisani M, Smart D, Gunthorpe MJ, et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 2002; 5: 546-51.
7. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400: 452-7.
8. Hwang SW, Cho H, Kwak J, et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000; 97: 6155-60.
9. Lee KJ, Vos R, Tack J. Effects of capsaicin on the sensorimotor function of the proximal stomach in humans. Aliment Pharmacol Ther 2004; 19: 415-25.
10. Schmidt B, Hammer J, Holzer P, Hammer HF. Chemical nociception in the jejunum induced by capsaicin. Gut 2004; 53: 1109-16.
11. Drewes AM, Schipper K-P, Dimcevski G, et al. Gut pain and hyperalgesia induced by capsaicin: a human experimental model. Pain 2003; 104: 333-41.
12. Hammer J. Hyperalgesia against capsaicin in subjects with uninvestigated dyspepsia: potential as a new diagnostic test. Wien Klin Wochenschr 2006; 118: 43-8.
13. Hammer J, Hammer HF, Eherer AJ, Petritsch W, Holzer P, Krejs GJ. Intraluminal capsaicin does not affect fluid and electrolyte absorption in the human jejunum but causes pain. Gut 1998; 43: 252-5.
14. Mearin F, Cucala M, Azpiroz F, Malagelada JR. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991; 101: 999-1006.
15. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology 1991; 100: 1311-8.
16. Moriarty KJ, Dawson AM. Functional abdominal pain: further evidence that the whole gut is affected. BMJ 1992; 284: 1670-2.
17. Coffin B, Azpiroz F, Guarner F, Malagelada J-R. Selective gastric hypersensitivity and reflex hyproreactivity in functional dyspepsia. Gastroenterology 1994; 107: 1345-51.
18. Moss HE, Sanger GJ. The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension. Br J Pharmacol 1990; 100: 497-501.
19. Coffin B, Bouhassira D, Chollet R, et al. Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment Pharmacol Ther 1996; 10: 919-25.
20. Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004; 127: 1239-55.
21. Bortolotti M, Coccia G, Grossi G, Miglioli M. The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 2002; 16: 1075-82.
22. Accarino AM, Azpiroz F, Malagelada J-R. Gut perception in humans is modulated by interacting gut stimuli. Am J Physiol Gastrointest Liver Physiol 2002; 282: G220-5.
23. Gebhart GF. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications: IV. Visceral afferent contribution to the pathobiology of visceral pain. Am J Physiol Gastrointest Liver Physiol 2000; 278: G834-8.
24. Rodriguez-Stanley S, Collings KL, Robinson M, Owen W, Miner JR. The effects of capsaicin on reflux, gastric emptying and dyspepsia. Aliment Pharmacol Ther 2000; 14: 129-34.
25. Holzer P. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur J Pharmacol 2004; 500: 231-41.
26. Jancsó N. Role of the nerve terminals in the mechanism of inflammatory reactions. Bull Millard Fillmore Hosp 1960; 7: 53-77.
27. Numazaki M, Tominaga T, Takeuchi K, Murayama N, Toyooka H, Tominaga M. Structural determinant of TRPV1 desensitization interacts with calmodulin. Proc Natl Acad Sci U S A 2003; 100: 8002-6.
28. Hammer J, Matiasek J, Ban S. Hypersensitivity against intragastric capsaicin in patients with non-ulcer dyspepsia. Gut 2006; 55 (Suppl. II): A22.
29. Kato S, Aihara E, Nakamura A, et al. Expression of vanilloid receptors in rat gastric epithelial cells: role in cellular protection. Biochem Pharmacol 2003; 66: 1115-21.
30. - response. Dig Dis Sci 2003; 48: 1850-6.
31. Horie S, Yamamoto H, Michael GJ, et al. Protective role of vanilloid receptor type 1 in HCL-induced gastric mucosal lesions in rats. Scand J Gastroenterol 2004; 39: 303-12.
32. Maggi CA, Patacchini R, Santicioli P, et al. Specific motor effects of capsaicin on human jejunum. Eur J Pharmacol 1988; 149: 393-5.
33. Maggi CA, Giuliani S, Santicioli P, et al. Direct evidence for the involvement of vasoactive intestinal polypeptide in the motor response of the human isolated ileum to capsaicin. Eur J Pharmacol 1990; 185: 169-78.
34. Shibata C, Sasaki I, Naito H, Ueno T, Matsuno S. Intragastric capsaicin stimulates motility of upper gut and proximal colon via distinct pathways in conscious dogs. Dig Dis Sci 1999; 44: 1083-9.
35. Shibata C, Jin XL, Naito H, Matsuno S, Sasaki I. Intraileal capsaicin inhibits gastrointestinal contractions via a neural reflex in conscious dogs. Gastroenterology 2002; 123: 1904-11.
36. Yiangou Y, Facer P, Dyer NH, et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001; 357: 1338-9.
37. Guo A, Vulchanova L, Wang J, Li X, Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 1999; 11: 946-58.
38. Michael GJ, Priestley JV. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J Neurosci 1999; 19: 1844-54.
39. Ward SM, Bayguinov J, Won KJ, Grundy D, Berthoud HR. Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J Comp Neurol 2003; 465: 121-35.
40. Holzer P. Sensory neuron responses to mucosal noxae in the upper gut: relevance to mucosal integrity and gastrointestinal pain. Neurogastroenterol Motil 2002; 14: 1449-75.
41. Holzer P. Tachykinins as targets of gastroenterological pharmacotherapy. Drugs News Perspect 1998; 11: 394-401.
42. Patacchini R, Maggi CA. Peripheral tachykinin receptors as targets for new drugs. Eur J Pharmacol 2001; 429: 13-21.
43. Camilleri M. Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol 2004; 141: 1237-48.
44. Chan CLH, Facer P, Davis JB, et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2003; 361: 385-91.
45. Urban L, Campbell EA, Panesar M, et al. In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue. Pain 2000; 89: 65-74.
46. Wang Y, Szabo T, Welter JD, et al. High affinity antagonists of the vanilloid receptor. Mol Pharmacol 2002; 62: 947-56.